UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046547
Receipt number R000053107
Scientific Title The retrospective study for Vonoprazan, clarithromycin, and metronidazole regimen for Helicobacter pylori eradication therapy for patients with penicillin allergy in view of clarithromycin-resistance
Date of disclosure of the study information 2022/01/05
Last modified on 2022/01/05 13:53:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The retrospective study for Vonoprazan, clarithromycin, and metronidazole regimen for Helicobacter pylori eradication therapy for patients with penicillin allergy in view of clarithromycin-resistance

Acronym

The retrospective study for Vonoprazan, clarithromycin, and metronidazole regimen for Helicobacter pylori eradication therapy for patients with penicillin allergy in view of clarithromycin-resistance

Scientific Title

The retrospective study for Vonoprazan, clarithromycin, and metronidazole regimen for Helicobacter pylori eradication therapy for patients with penicillin allergy in view of clarithromycin-resistance

Scientific Title:Acronym

The retrospective study for Vonoprazan, clarithromycin, and metronidazole regimen for Helicobacter pylori eradication therapy for patients with penicillin allergy in view of clarithromycin-resistance

Region

Japan


Condition

Condition

Helicobacter pylori for patients with penicillin allergy

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of treatment with bonoprazan, clarithromycin, and metronidazole for penicillin-allergic, clarithromycin-resistant Helicobacter pylori infection.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Efficacy of different treatment methods (proton pump inhibitor/bonoprazole + clarithromycin + metronidazole, bonoprazole + metronidazole + sitafloxatin) for penicillin-allergic Helicobacter spp. positive patients at our hospital(To be determined by urea breath test at least 2 months after completion of administration)

Key secondary outcomes

Safety of Treatment
Comparison of the difference in efficacy of the following eradication treatments in patients treated with bonoprazan, clarithromycin, and metronidazole with and without clarithromycin resistance


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

PPI (esomeprazole 20mg 2T, lansoprazole 30mg 2T, or rabeprazole na 10mg 2Tb) + clarithromycin 200mg 2T + MNZ 250mg 2T for 7 days

Interventions/Control_2

Bonoprazole 20 mg 2 T+ clarithromycin 200mg 2T + MNZ 250mg 2T for 7 days

Interventions/Control_3

Bonoprazole 20 mg 2 T+sitafloxacin50mg 2T + MNZ 250mg 2T for 7 days

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Penicillin-allergic patients who received eradication treatment for Helicobacter pylori at our hospital

Key exclusion criteria

In the case that the current infection of Helicobacter pylori cannot be confirmed
If you do not wish to pay for your own treatment

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Sasaki

Organization

Aichi-medical university of medicine

Division name

gastroenterology

Zip code

4801103

Address

1-1Karimata Yazako ngakute city Aichi

TEL

0561623311

Email

sasaki.makoto.900@mail.aichi-med-u.ac.jp


Public contact

Name of contact person

1st name kazunori
Middle name
Last name Adachi

Organization

Aichi-medical university of medicine

Division name

gastroenterology

Zip code

4801103

Address

1-1Karimata Yazako ngakute city Aichi

TEL

0561623311

Homepage URL


Email

k.adachi@aichi-med-u.ac.jp


Sponsor or person

Institute

Aichi-medical university of medicine

Institute

Department

Personal name



Funding Source

Organization

Aichi-medical university of medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aichi-medical university of medicine

Address

1-1Karimata Yazako ngakute city Aichi

Tel

0561623311

Email

k.adachi@aichi-med-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 06 Month 01 Day

Date of IRB

2015 Year 02 Month 24 Day

Anticipated trial start date

2021 Year 06 Month 01 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 01 Month 05 Day

Last modified on

2022 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053107